Alpha 2.0
Login Register
» Authors » Sudarshawn Damodharan

Sudarshawn Damodharan

Explore the profile of Sudarshawn Damodharan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 25
Followers 0
Related Specialties
Pediatrics
Oncology
Hematology
Top 10 Co-Authors
Mahua Dey
Diane Puccetti
Jeffrey Helgager
Elliot Xie
Christian M Capitini
Istvan Danko
Cathy Lee-Miller
Bermans Iskandar
Emily Distler
Anthony Salvatore
Published In
Childs Nerv Syst
Pediatr Rev
Pediatr Blood Cancer
Clin Pediatr (Phila)
WMJ
Affiliations
Soon will be listed here.
Recent Articles
1.
Transcriptomic and proteomic spatial profiling of pediatric and adult diffuse midline glioma H3 K27-Altered
Damodharan S, Shireman J, Xie E, Distler E, Kendziorski C, Dey M
Sci Rep . 2024 Sep; 14(1):22668. PMID: 39349581
Diffuse midline glioma, H3 K27-altered (DMG) are highly aggressive malignancies of the central nervous system (CNS) that primarily affect the pediatric population. Large scale spatial transcriptomic studies have implicated that...
2.
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas
Bender J, Damodharan S, Capitini C, Moskop A, Toner K, Vatsayan A, et al.
Blood Adv . 2024 Jun; 8(15):4164-4168. PMID: 38916857
No abstract available.
3.
Increased Incidence of Retinoblastoma in Wisconsin: Coincidence or Public Health Concern?
Damodharan S, Monroe E
WMJ . 2024 May; 123(2):76-77. PMID: 38718232
No abstract available.
4.
Transcriptomic and Proteomic Spatial Profiling of Pediatric and Adult Diffuse Midline Glioma H3 K27-Altered, Reveals Region Specific Differences and Limited Overlap between mRNA and Protein
Damodharan S, Shireman J, Xie E, Distler E, Kendziorski C, Dey M
Res Sq . 2024 Apr; PMID: 38645012
Diffuse midline glioma, -altered (DMG-Alt) are highly aggressive malignancies of the central nervous system (CNS) that primarily affect the pediatric population. Large scale spatial transcriptomic studies have implicated that tumor...
5.
Inv(3) Acute Myeloid Leukemia in a Young Adult and Review of the Literature
Blakemore C, Damodharan S, Puccetti D
Case Rep Oncol Med . 2023 Nov; 2023:6628492. PMID: 38026762
Acute myeloid leukemia (AML) with the high-risk variant inv(3)/t(3;3) or t(3;3)(q21;26.2) is rarely seen in the pediatric and young adult population. It is associated with poor outcomes with ineffective therapeutic...
6.
Severe Hypercalcemia and Lytic Lesions in a 10-Year-Old Female
Salvatore A, Damodharan S, Paloian N, Lee-Miller C
Clin Pediatr (Phila) . 2023 Aug; 63(6):859-862. PMID: 37644741
No abstract available.
7.
Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations
Damodharan S, Puccetti D
Brain Sci . 2023 Jul; 13(7). PMID: 37509034
Pediatric central nervous system (CNS) tumors are the most common solid tumor in children, with the majority being glial in origin. These tumors are classified by the World Health Organization...
8.
Use of milrinone to support therapy-induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high-risk FLT3+ acute myeloid leukemia
Gerhartz B, Damodharan S, Puccetti D, Boriosi J, Hokanson J, Capitini C
Pediatr Blood Cancer . 2023 Jul; 70(10):e30542. PMID: 37485552
No abstract available.
9.
Molecular Characterization and Treatment Approaches for Pediatric -Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data
Damodharan S, Abbott A, Kellar K, Zhao Q, Dey M
Cancers (Basel) . 2023 Jul; 15(13). PMID: 37444588
Diffuse midline glioma (DMG), -altered are highly aggressive, incurable central nervous system (CNS) tumors. The current standard palliative treatment is radiotherapy, with most children succumbing to the disease in less...
10.
Need for pneumococcal revaccination after blinatumomab therapy: A case report
Voelz K, Salvatore A, Damodharan S, Lee-Miller C
Pediatr Blood Cancer . 2023 Feb; 70(6):e30237. PMID: 36726210
No abstract available.